Jakavi (ruxolintib)

pCPA File Number: 20754
Negotiation Status:
Concluded with an LOI
Indication(s):
Myelofibrosis
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CADTH Project Number:
pCODR 10012
pCPA Engagement Letter Issued:
Negotiation Process Concluded: